- Latest week
- 10 Jul 2026
- Close
- 7.600000
- Fair value
- 4.096395
- Next-week expectancy
- Undecided 47.00%
HAMLET-B Chart Pack
Hamlet BioPharma AB ser. B
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, HAMLET-B fell 5.00%, moving from 8.00 to 7.60. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 13.46 and has softened across the 12-week window. Market Dynamics is -0.65 on the latest week. Next-week expectancy is undecided at 47.00% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 7.60
- 12-Week Change
- -5.00%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 47.00%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 13.46
- Market Dynamics
- -0.65
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 7.60
- 12-Week Change
- -5.00%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 47.00%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 13.46
- Market Dynamics
- -0.65
Over the latest 12 completed weeks ending 2026-07-10, HAMLET-B fell 5.00%, moving from 8.00 to 7.60. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 13.46 and has softened across the 12-week window. Market Dynamics is -0.65 on the latest week. Next-week expectancy is undecided at 47.00% based on similar historical setup states.
Industry Peers
Sweden equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| ALZ Alzinova AB (publ) | STO | 10 Jul 2026 | 0.51 | 1.61 | 0.48 | 0.70 | 38.61% |
| NXTCL NextCell Pharma AB | STO | 10 Jul 2026 | 0.95 | 1.25 | 0.92 | 1.18 | 24.42% |
| BIOSGN Biosergen AB (publ) | STO | 10 Jul 2026 | 5.10 | 6.70 | 5.10 | 6.25 | 22.55% |
| SYNACT SynAct Pharma AB | STO | 10 Jul 2026 | 18.88 | 23.50 | 17.90 | 21.80 | 15.47% |
| RESP Respiratorius AB | STO | 10 Jul 2026 | 2.92 | 3.42 | 2.61 | 3.25 | 11.30% |
| BIOVIC-B Biovica International AB (publ) | STO | 10 Jul 2026 | 0.37 | 0.44 | 0.36 | 0.41 | 10.27% |
| IRLAB-A IRLAB Therapeutics AB (publ) | STO | 10 Jul 2026 | 1.27 | 1.43 | 1.27 | 1.40 | 9.91% |
| IMMU Mendus AB (publ) | STO | 10 Jul 2026 | 6.21 | 7.24 | 6.06 | 6.82 | 9.82% |
| PILA Pila Pharma AB (publ) | STO | 10 Jul 2026 | 1.21 | 1.57 | 1.21 | 1.31 | 8.26% |
| FLUI Fluicell AB (publ) | STO | 10 Jul 2026 | 34.00 | 37.00 | 34.00 | 36.00 | 5.88% |
| CHOSA CHOSA Oncology AB | STO | 10 Jul 2026 | 0.75 | 0.80 | 0.74 | 0.79 | 5.87% |
| APTA Aptahem AB (publ) | STO | 10 Jul 2026 | 0.60 | 0.69 | 0.60 | 0.63 | 5.00% |
| EGTX Egetis Therapeutics AB (publ) | STO | 10 Jul 2026 | 5.84 | 6.30 | 5.63 | 6.08 | 4.11% |
| CLBIO Corline Biomedical AB | STO | 10 Jul 2026 | 17.00 | 18.35 | 16.50 | 17.45 | 2.65% |
| DMYD-B Diamyd Medical AB (publ) | STO | 10 Jul 2026 | 1.12 | 1.20 | 1.06 | 1.14 | 1.79% |
| ACOU AcouSort AB (publ) | STO | 10 Jul 2026 | 3.70 | 3.88 | 3.58 | 3.75 | 1.35% |